Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Simmons

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|February 16, 2026
Molecular and Serological Evidence of Oropouche Virus Circulation in Asymptomatic Blood Donors During the 2023-2024 Outbreak in Manaus, BrazilPamela Milani, Graham Simmons, Allyson Guimarães da Costa, et al.
Transfusion|June 14, 2021
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillanceClara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Transfusion|February 24, 2017
First cases of Zika virus-infected US blood donors outside states with areas of active transmissionPhillip C Williamson, Jeffrey M Linnen, Debra A Kessler, et al.
Cell Reports|December 22, 2015
Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral PathogenesisJing Jin, Nathan M Liss, Dong-Hua Chen, et al.
Journal of Virology|October 3, 2014
Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacyRachel H Fong, Soma S R Banik, Kimberly Mattia, et al.
Cell|November 11, 2015
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and EgressJulie M Fox, Feng Long, Melissa A Edeling, et al.
Transfusion|October 7, 2024
Spike and nucleocapsid antibody dynamics following SARS-CoV-2 infection and vaccination: Implications for sourcing COVID-19 convalescent plasma from routinely collected blood donationsClara Di Germanio, Xutao Deng, Brendan G Balasko, et al.
Emerging Infectious Diseases|April 20, 2019
Serologic Prevalence of Ebola Virus in Equatorial AfricaImke Steffen, Kai Lu, Lauren K Yamamoto, et al.
Plos One|October 3, 2012
In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancerDeanna Lee, Jaydip Das Gupta, Christina Gaughan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance ProgramMars Stone, Clara Di Germanio, David J Wright, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|February 16, 2026
Molecular and Serological Evidence of Oropouche Virus Circulation in Asymptomatic Blood Donors During the 2023-2024 Outbreak in Manaus, BrazilPamela Milani, Graham Simmons, Allyson Guimarães da Costa, et al.
Transfusion|June 14, 2021
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillanceClara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Transfusion|February 24, 2017
First cases of Zika virus-infected US blood donors outside states with areas of active transmissionPhillip C Williamson, Jeffrey M Linnen, Debra A Kessler, et al.
Cell Reports|December 22, 2015
Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral PathogenesisJing Jin, Nathan M Liss, Dong-Hua Chen, et al.
Journal of Virology|October 3, 2014
Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacyRachel H Fong, Soma S R Banik, Kimberly Mattia, et al.
Cell|November 11, 2015
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and EgressJulie M Fox, Feng Long, Melissa A Edeling, et al.
Transfusion|October 7, 2024
Spike and nucleocapsid antibody dynamics following SARS-CoV-2 infection and vaccination: Implications for sourcing COVID-19 convalescent plasma from routinely collected blood donationsClara Di Germanio, Xutao Deng, Brendan G Balasko, et al.
Emerging Infectious Diseases|April 20, 2019
Serologic Prevalence of Ebola Virus in Equatorial AfricaImke Steffen, Kai Lu, Lauren K Yamamoto, et al.
Plos One|October 3, 2012
In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancerDeanna Lee, Jaydip Das Gupta, Christina Gaughan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance ProgramMars Stone, Clara Di Germanio, David J Wright, et al.
Pageof 13